FIELD: organic chemistry, medicine.
SUBSTANCE: invention relates to a novel using to compounds of the general formula (I): 
. Also, invention relates to preparing a medicinal agent used for modulating sodium channels and, in particular, in treatment of pain (for example, neuropathic pain), epilepsy, neurodegenerative states and bipolar states.
EFFECT: valuable medicinal properties of compounds.
10 cl, 18 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL DERIVATIVES OF ARYLIMIDAZOLE, THEIR PREPARATIONS AND THEIR THERAPEUTIC USES | 2003 |
|
RU2323216C2 |
| DERIVATIVES OF FIVE-MEMBER HETEROCYCLES, METHOD OF PRODUCTION AND USE THEREOF AS MEDICINAL AGENTS | 2000 |
|
RU2380362C2 |
| FIVE-MEROUS HETEROCYCLE DERIVATIVES, METHOD FOR PREPARING AND USING THEM AS THERAPEUTIC AGENTS | 2009 |
|
RU2530882C2 |
| DERIVATIVES OF FIVE-MEMBERED HETEROCYCLES, METHOD FOR THEIR PREPARING AND THEIR USING AS MEDICINES | 2000 |
|
RU2271355C2 |
| MODULATORS OF SODIUM CHANNELS REPRESENTING DERIVATIVES OF 2-PIPERIDYLIMIDAZOLES | 2001 |
|
RU2275369C2 |
| PREPARATION COMPRISING INHIBITOR OF HETEROTRIMERIC G PROTEINS SIGNAL TRANSDUCTION IN COMBINATION WITH OTHER CYTOSTATIC AGENT FOR THERAPEUTIC USING IN CANCER TREATMENT | 2000 |
|
RU2298417C2 |
| DERIVATIVES OF FIVE-MEMBERED HETEROCYCLES, THEIR PREPARING AND USING AS MEDICINAL AGENTS | 2002 |
|
RU2288224C2 |
| TAXANE SYNTHESIS INTERMEDIATES AND METHODS OF PREPARATION THEREOF | 1996 |
|
RU2159237C2 |
| 3-(5)-HETEROARYL-SUBSTITUTED PYRAZOLES AS KINASE P38 INHIBITORS | 1998 |
|
RU2249591C2 |
| PRODUCT COMPRISING AT LEAST ONE SUBSTANCE INHIBITING ACTIVITY OF NO-SYNTHASE IN COMBINATION WITH AT LEAST ONE SUBSTANCE INHIBITING ACTIVITY OF PHOSPHOLIPASE A | 2000 |
|
RU2256465C2 |
